{
  "ticker": "CRL",
  "company": "Charles River Laboratories",
  "quarter": "Q3 2025",
  "date": "2025-07-28",
  "content": "Charles River Laboratories Financial Overview\nData as of: 2025-07-28\n\nCompany Metrics:\nStock Price: $0.83\nMarket Cap: $1,841,422,719\n52-Week High: $1.08\n52-Week Low: $0.58\n\nValuation Metrics:\nP/E Ratio (TTM): 11.0\nForward P/E: 9.9\nPEG Ratio: 2.40\nPrice to Book: 2.0\n\nFinancial Performance:\nRevenue (TTM): $301,349,599\nRevenue Growth (YoY): 16.8%\nGross Margin: 31.6%\nOperating Margin: 7.4%\nNet Margin: 3.6%\n\nProfitability:\nReturn on Assets: 26.3%\nReturn on Equity: 28.0%\nProfit Margin: 3.6%\n\nTrading Information:\nBeta: 2.00\nDividend Yield: 2.03%\nPrevious Close: $0.81\nDay Range: $0.80 - $0.85\nVolume: 8,000,792\nAverage Volume: 17,912,347",
  "source": "batch-cache",
  "cached_at": "2025-07-28T21:15:02.822640"
}